Browsing by Author "Callejo Perez, Ana"
Now showing items 1-9 of 9
-
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer
Callejo Perez, Ana; Bar, Jair; Berchem, Guy; Bazhenova, Lyudmila; Saintigny, Pierre; Felip Font, Enriqueta; Solomon, Benjamin (Wiley, 2022-07) -
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
Cedres Perez, Susana; Assaf, Juan David; Iranzo Gómez, Patricia; Callejo Perez, Ana; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Marmolejo Castañeda, David; Rezqallah Aron, Maria Alejandra; Amat, Ramon; Pedrola Gómez, Anna; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan; Dienstmann, Rodrigo (Nature Research, 2021-11-01) -
Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report
Mirallas Viñas, Oriol; Pardo Aranda, Nuria; Aubanell, Anton; Salcedo Allende, Maria Teresa; Callejo Perez, Ana; Iranzo Gómez, Patricia; Tabernero Caturla, Josep; Felip Font, Enriqueta; Bosch Schips, Marc (Frontiers Media, 2022-03) -
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC
Iranzo Gómez, Patricia; Pardo Aranda, Nuria; Callejo Perez, Ana; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Soleda, Mireia; Jiménez Flores, José Antonio; Hernandez Losa, Javier; Vivancos Prellezo, Ana; Felip Font, Enriqueta; Amat, Ramon; Carbonell, Caterina; Frigola Rissech, Joan (BMJ, 2022-04) -
Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients
Callejo Perez, Ana; Iranzo Gómez, Patricia; Diaz-Mejia, Nely; Marmolejo Castañeda, David; Assaf, Juan David; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Pardo Aranda, Nuria; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (MDPI, 2021-07) -
Long duration of immunotherapy in a STK11 mutated/KRAS wild-type non-small cell lung cancer patient
Domingues, I.; Cedres Perez, Susana; Callejo Perez, Ana; Vivancos Prellezo, Ana; Martínez Marti, Alexandre; Felip Font, Enriqueta (Elsevier, 2020-01) -
Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
Navarro Mendivil, Alejandro; Callejo Perez, Ana; Iranzo Gómez, Patricia; Cedres Perez, Susana; Martínez Marti, Alexandre; Pardo Aranda, Nuria; Jiménez Flores, José Antonio; Sansano Valero, Irene; Mancuso, Francesco Mattia; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Felip Font, Enriqueta; Amat, Ramon; Saoudi Gonzalez, Nadia; Carbonell, Caterina; Frigola Rissech, Joan (Wiley, 2021-04) -
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Iranzo Gómez, Patricia; Callejo Perez, Ana; Assaf Pastrana, Juan David; Molina, Gaspar; Lopez, Daniel Esteban; García Illescas, David; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Cedres Perez, Susana; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (Frontiers Media, 2022-05-30) -
The Low Incidence of Viral Hepatitis Reactivation Among Subjects on Immunotherapy Reduces the Impact of Suboptimal Screening Rate
Aceituno, Laia; Bañares Sanchez, Juan; Ruiz-Ortega, Lourdes; Callejo Perez, Ana; Diaz-Mejia, Nely; Barreira Diaz, Ana; Farriols Danes, Anna Maria; Riveiro Barciela, Maria del Mar; Buti Ferret, Maria; Carreras Soler, Maria Josep; Ortiz Velez, Carolina; Muñoz Couselo, Eva (Frontiers Media, 2022-07-15)